Surrounded by his family, Edward W. Behr passed away peacefully on June 5, 2025, at Garnet Health Medical Center in Wallkill, NY. He was 71 years old. Son of the late Kenneth and Ethel (Shields ...

Greg Behr, a self-described "geriatric millennial," challenges the conventional wisdom of generational branding, arguing it oversimplifies diverse experiences and stifles meaningful engagement.

Kevin Abstract's 'Blush' Is a Heartfelt Homage to Houston: A hometown-inspired LP lifted by a lineup of local artists and close collaborators that reiterates Abstract's superhuman sonic capabilities.

In addition to the sunscreen, Dr. Behr says a face wash and moisturizer is also a good place to start. But adds, at that young age, it's best to keep the facial routine simple.

Producer/songwriter Kevin Abstract and longtime collaborator and friend Dominic Fike have released "Geezer" as the latest taster of Abstract’s forthcoming collective album, BLUSH. "Geezer" is Fike and ...

Research that is taking a closer look at activity in the thalamus—a region long considered a relay station for the brain and involved in consciousness and motor activity—reveals the thalamus ...

The British artist and film-maker Steve McQueen presents his most abstract work to date with the light-and-sound sculpture Bass (2024). The piece marks a compelling turn in the artist’s ongoing ...

President Donald Trump’s abrupt firing Friday of Nuclear Regulatory Commissioner Christopher Hanson marks another move by the White House to gain control of the independent agency as it heads ...

For those who want to dig even deeper, here are the week's new albums sorted by genre: Pop. Lorde, Virgin Lizzo, My Face Hurts From Smiling Kevin Abstract, Blush Lauren Spencer Smith, The Art of ...

Abstract Background. In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to fasting blood glucose levels.

Meeting Abstract: 2025 ASCO Annual Meeting II. Free access. Head and Neck Cancer. June 04, 2025. Share on. NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to ...